| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.13 | 0.3 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |